Product hub: Targeted protein degradation – next-generation therapeutics
Helen Harrison, Director of Screening at Amphista Therapeutics, discusses targeted protein degradation (TPD) and the discovery of drugs in this area.
List view / Grid view
Helen Harrison, Director of Screening at Amphista Therapeutics, discusses targeted protein degradation (TPD) and the discovery of drugs in this area.
Discover why the Hyperion+ Imaging System is the standard to assess tumour-immune interactions and get deep single-cell insights.
The pipetting robot, flowbot® ONE, is available with UV light to make clean-up processes easy and effective, enabling you to keep your samples safe.
Ensuring that drug candidates can reach the clinic is no easy task, so having models that can closely represent human pathology is crucial. Here, Dr Beth Hoffman, CEO of Origami Therapeutics, describes the successes and challenges of using human disease cell models in drug discovery.
Download this infographic to find out why the method of generating human iPSC-derived cells matters.
7 September 2022 | By Sartorius
Watch this webinar to hear from Dr Yuansheng Yang as he introduces a CHO cell-based technology allowing simultaneous display and secretion of antibodies for accelerating the process of antibody development.
19 August 2022 | By Sartorius
Want to learn about the latest research and development of cell models in rare diseases? Then watch this virtual panel discussion to hear from industry experts.
The AI algorithm was able to predict the presence and the location of nuclei in more than 8,000 cells.
R&D Systems offers custom antibody production services to engineer the right antibody to solve your research question with confidence.
27 July 2022 | By Molecular Devices & HeartBeat.bio
Watch this virtual panel discussion to identify ways to overcome common challenges in 3D biology research, regardless of where you are in your journey.
Find western blot application protocols and troubleshooting tips for detecting proteins in this handbook.
View markers for human immune cell characterisation by flow cytometry in relevant cell subsets including B Cells, T Cells, NK Cells and ILCs.
A new insight into the way the EGF receptor sends signals into cells could help researchers design new cancer drugs that target this protein.
In a pre-clinical study, researchers from the US set out to develop a treatment for sepsis. Here, Daniel Morales-Mantilla, Dr Robin Parihar and Dr Katherine King, from Baylor College of Medicine, describe how they utilised haematopoietic stem and progenitor cell infusion to improve the survival of mice from sepsis.
This infographic will explore Mycoplasma contamination in cell cultures and the best technologies for detection.